Artificial Intelligence: CDER’s New Council Takes Charge Of Oversight, Coordination

The Artificial Intelligence Council takes over work that three different entities in the US FDA’s drugs center had been performing. The new, centralized entity will develop and promote consistency in AI-related activities and advance innovative uses.

Chess piece
• Source: Shutterstock

The US FDA’s Center for Drug Evaluation and Research is consolidating oversight and coordination of all internal and external artificial intelligence efforts into one centralized entity.

More from Digital Technologies

More from HBW Insight